Cosmo Pharmaceuticals
C43.F
#5654
Rank
HK$6.99 B
Marketcap
HK$423.16
Share price
-4.40%
Change (1 day)
-30.36%
Change (1 year)

Earnings for Cosmo Pharmaceuticals (C43.F)

Earnings in 2024: HK$1.23 Billion

According to Cosmo Pharmaceuticals's latest financial reports the company's current earnings are HK$0.27 Billion. In 2024 the company made an earning of HK$1.23 Billion, an increase over its 2023 earnings that were of -HK$55.65 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cosmo Pharmaceuticals from 2004 to 2024

Annual earnings

Year Earnings Change
2024HK$1.23 B-2324.85%
2023-HK$55.65 Million-127.33%
2022HK$0.20 B-3.43%
2021HK$0.21 B-418.87%
2020-HK$66.14 Million-64.28%
2019-HK$0.19 Billion19.49%
2018-HK$0.16 Billion-48.67%
2017-HK$0.31 Billion-234.57%
2016HK$0.22 B-89.6%
2015HK$2.15 B110.02%
2014HK$1.02 B33.75%
2013HK$0.76 B177.69%
2012HK$0.27 B201.84%
2011HK$91.6 M99.1%
2010HK$46.01 M-22.14%
2009HK$59.09 M-53.08%
2008HK$0.12 B7167.3%
2007HK$1.73 M-66.41%
2006HK$5.15 M-57.18%
2005HK$12.04 M-193.84%
2004-HK$12.84 Million